In a mouse model of AD, heterozygosity of Reln increases the accumulation of Aβ plaques (Kocherhans et al., 2010), suggesting that the pathway physiologically alters APP cleavage in a manner that would protect against AD. Here, RELN is linked to Alzheimer disease.